CONTIPRO AS -  

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2019-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 3.497.298 234.872 1
2019 0 3.962.143 234.872 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS1
EUROPEAN LABORATORY FOR NON LINEAR SPECTROSCOPY1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
HOCHSCHULE BIBERACH1
MYBIOTECH1
NATIONAL UNIVERSITY OF IRELAND GALWAY1
NEOS SURGERY S L1
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON1
SYDDANSK UNIVERSITET1
UNIVERSITA DEGLI STUDI GABRIELE D'ANNUNZIO DI CHIETIPESCARA1
UNIVERSITAET BERN1
UNIVERSITE JOSEPH FOURIER GRENOBLE 11
UNIVERSITEIT ANTWERPEN1
UNIVERSITY OF CAMBRIDGE1
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER1

Constancy:

Total number of partners: 15
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 15
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2021-01-01Nose-to-Brain Delivery of Biopharmaceutics for the therapy of central nervous system diseases: A design-based approach for efficient drug delivery systems Bio2Brainparticipant3.497.2989
2019-05-01Novel Biomaterial-based Device for the Treatment of Progressive MS- - An Integrated Pan- European Approach PMSMatTrainparticipant3.962.1438